Treatment of Hypophysitis in Symptomatic Hyperprolactinaemia

In patients with Hypophysitis presenting with symptomatic hyperprolactinaemia, the clinical approach requires careful, protocol-guided management to address the hormonal derangement and its consequences.

Clinical Scenario

This protocol applies to Hypophysitis occurring in the setting of symptomatic hyperprolactinaemia — elevated prolactin levels causing clinical manifestations that warrant active therapeutic intervention.

Treatment Approach

Management in this setting centres on dopamine agonist therapy, with the specific choice of agent and the approach to dose titration guided by the individual's serum prolactin response. Full agent selection criteria, sequencing, and monitoring targets are detailed in the structured regimen.

Instant Access to Structured Evidence-Based Regimens

References

Symptomatic hyperprolactinaemia is treated with dopamine agonists (cabergoline, bromocriptine) and the dosage adjusted based on serum prolactin levels.

DOI: 10.1016/j.beem.2019.101371

View source ↗